Greig named non-executive chair at Nucleome

Nucleome Therapeutics Ltd. named Russell Greig as non-executive chair. Greig, a 30-year veteran of GSK plc (LSE:GSK; NYSE:GSK), is also chair at BiomX Inc. (NYSE:PHGE), eTheRNA immunotherapies N.V. and Cardior Pharmaceuticals GmbH. Nucleome is identifying targets for autoimmune diseases in the non-protein-coding “dark genome” using a technique to map the 3-D genome at single-base pair resolution. .

Sparx Group Co. Ltd. hired Ronald Meier as CMO, Meier was executive medical director at Kyowa Kirin Co. Ltd. (Tokyo:4151) and VP of immuno-oncology at Eli Lilly and Co. (NYSE:LLY)...